Montag & Associates’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6K Sell
5
-2
-29% -$754 ﹤0.01% 850
2026
Q1
$2.12K Hold
7
– – ﹤0.01% 844
2025
Q4
$1.43K Sell
7
-29
-81% -$4.98K ﹤0.01% 899
2025
Q3
$4.94K Buy
36
+17
+89% +$1.86K ﹤0.01% 826
2025
Q2
$1.7K Hold
19
– – ﹤0.01% 866
2025
Q1
$1.56K Sell
19
-3
-14% -$336 ﹤0.01% 914
2024
Q4
$2.75K Hold
22
– – ﹤0.01% 870
2024
Q3
$2.93K Hold
22
– – ﹤0.01% 897
2024
Q2
$3.24K Buy
22
+13
+144% +$1.65K ﹤0.01% 848
2024
Q1
$1.02K Hold
9
– – ﹤0.01% 925
2023
Q4
$977 Hold
9
– – ﹤0.01% 885
2023
Q3
$905 Hold
9
– – ﹤0.01% 873
2023
Q2
$1K Hold
9
– – ﹤0.01% 891
2023
Q1
$968 Hold
9
– – ﹤0.01% 893
2022
Q4
$786 Hold
9
– – ﹤0.01% 916
2022
Q3
$1K Hold
9
– – ﹤0.01% 852
2022
Q2
$1K Hold
9
– – ﹤0.01% 815
2022
Q1
$1K Sell
9
-2,038
-100% -$258K ﹤0.01% 831
2021
Q4
$335K Buy
+2,047
New +$288K 0.02% 334
2021
Q2
– Sell
-1,200
Closed -$146K – 890
2021
Q1
$146K Buy
1,200
+1,150
+2,300% +$144K 0.01% 428
2020
Q4
$6K Buy
+50
New +$5.11K ﹤0.01% 739

Other funds holding TER

Montag & Associates's TER Position: Q2 2026 in Review

Montag & Associates reduced its Teradyne (TER) stake by 29% in Q2 2026, selling an estimated $754 and leaving 5 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Montag & Associates first reported a position in TER in Q4 2020 and has held it in 21 quarters since. The position peaked at $335K in Q4 2021. 1,429 funds tracked by Wall St. Rank hold TER as of Q2 2026.

  • Montag & Associates held 5 shares of Teradyne worth $2.6K as of Q2 2026.
  • Montag & Associates sold 2 Teradyne shares in Q2 2026, an estimated $754.
  • Teradyne made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #850 holding.
  • Montag & Associates first reported a position in Teradyne in Q4 2020 and has held it in 21 quarters since.
  • Montag & Associates's Teradyne position peaked at $335K in Q4 2021.
  • 1,429 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.